Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
INO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.89%79.040.6%$449.17m
ABTAbbott Laboratories
-0.39%56.100.8%$358.34m
ISRGIntuitive Surgical, Inc.
1.07%373.522.5%$241.74m
TMOThermo Fisher Scientific Inc.
0.22%194.291.0%$230.92m
BDXBecton, Dickinson and Company
-0.34%211.111.3%$226.45m
ALGNAlign Technology, Inc.
0.94%202.766.3%$183.47m
DXCMDexCom, Inc.
-0.02%44.778.7%$171.88m
SYKStryker Corporation
-0.34%149.981.3%$159.65m
XRAYDENTSPLY International Inc.
-0.03%61.823.0%$142.38m
EWEdwards Lifesciences Corporation
0.95%114.151.2%$138.83m
BCRC. R. Bard, Inc.
-0.46%328.651.6%$131.64m
BAXBaxter International Inc.
0.85%64.131.7%$127.90m
ZBHZimmer Biomet Holdings, Inc.
-0.54%121.691.7%$126.06m
BSXBoston Scientific Corporation
-0.29%29.611.1%$121.49m
HOLXHologic, Inc.
0.51%37.201.6%$113.54m

Company Profile

Inovio Pharmaceuticals, Inc. is a bio pharmaceutical company. It develops active DNA immunotherapies for cancer and infectious diseases. The company's portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. Its pipeline consists vgx-3100, ino-3122, ino-3106, pennvax-b and pennvax-g. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.